Lewis Denise Riedel, Chen Huann-Sheng, Midthune Douglas N, Cronin Kathleen A, Krapcho Martin F, Feuer Eric J
Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland.
Biometry Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland.
Cancer. 2015 Jun 15;121(12):2053-62. doi: 10.1002/cncr.29304. Epub 2015 Mar 4.
The National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program collects and publishes population-based cancer incidence data from registries covering approximately 28% (seer.cancer.gov/registries/data.html) of the US population. SEER incidence rates are released annually in April from data submitted the prior November. The time needed to identify, consolidate, clean, and submit data requires the latest diagnosis year included to be 3 years before release. Approaches, opportunities, and cautions for an earlier release of data based on a February submission are described.
First, cases submitted in February for the latest diagnosis year represented 92% to 98% of those in the following November submission. A reporting delay model was used to statistically adjust counts in recent diagnosis years for cases projected in the future. February submissions required larger adjustment factors than November submissions. Second, trends were checked to assess the validity.
Most cancer sites had similar annual percent change (APC) trends for February and November 2013. Male colon and rectum cancer and female lung and bronchus cancer showed an acceleration in declining APC trends only in February. Average annual percent change (AAPC) trends for the 2 submissions were similar for all sites.
For the first time, preliminary 2012 incidence rates, based on February submissions, are provided. An accelerated decline starting in 2008 for male colon and rectum cancer rates and male lung cancer rates did not persist when 2012 data were added. An earlier release of SEER data is possible. Caution must be exercised when one is interpreting changing trends. Use of the more conservative AAPC is advised.
美国国家癌症研究所的监测、流行病学和最终结果(SEER)计划收集并发布基于人群的癌症发病率数据,这些数据来自覆盖约28%美国人口的登记处(seer.cancer.gov/registries/data.html)。SEER发病率数据于每年4月根据前一年11月提交的数据发布。识别、整合、清理和提交数据所需的时间要求所包含的最新诊断年份为发布年份的前3年。本文描述了基于2月提交的数据提前发布的方法、机会和注意事项。
首先,2月提交的最新诊断年份的病例数占次年11月提交病例数的92%至98%。使用报告延迟模型对未来预计病例的近期诊断年份的计数进行统计调整。2月提交的数据需要比11月提交的数据更大的调整因子。其次,检查趋势以评估有效性。
大多数癌症部位在2013年2月和11月的年度百分比变化(APC)趋势相似。男性结肠癌和直肠癌以及女性肺癌和支气管癌仅在2月显示出下降的APC趋势加速。两个提交数据的所有部位的平均年度百分比变化(AAPC)趋势相似。
首次提供了基于2月提交数据的2012年初步发病率。当加入2012年数据时,2008年开始的男性结肠癌和直肠癌以及男性肺癌发病率的加速下降趋势并未持续。SEER数据的提前发布是可能的。在解释变化趋势时必须谨慎。建议使用更保守的AAPC。